Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion

References

• Adams, J. (2004). The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4:349–360.
   PubMed Web of Science ®Google Scholar
• Ashkenazi, A., Dixit, V. M. (1998). Death receptors: signaling and modulation. Science 281:1305–1308.
   PubMed Web of Science ®Google Scholar
• Blenis, J. (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90:5889–5892.
   PubMed Web of Science ®Google Scholar
• Budihardjo, I., Oliver, H., Lutter, M., Luo, X., Wang, X. (1999). Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269–290.
   PubMed Web of Science ®Google Scholar
• Chen, T. J., Jeng, J. Y., Lin, C. W., Wu, C. Y., Chen, Y. C. (2006). Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223:113–126.
   PubMed Web of Science ®Google Scholar
• Dasmahapatra, G., Rahmani, M., Dent, P., Grant, S. (2006). The tyrphostin, adaphostin, interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107:232–240.
   PubMed Web of Science ®Google Scholar
• Drexler, H. C. (1997). Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci U S A 94:855–860.
   PubMed Web of Science ®Google Scholar
• Emanuele, S., et al. (2002). Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor, MG132, is associated with hydrogen peroxide production, expression of Bcl-XS, and activation of caspase-3. Int J Oncol 21:857–865.
   PubMed Web of Science ®Google Scholar
• Estrela, J. M., Ortega, A., Obrador, E. (2006). Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143–181.
   PubMed Web of Science ®Google Scholar
• Genestra, M. (2007). Oxyl radicals, redox-sensitive signalling cascades, and antioxidants. Cell Sign 19:1807–1819.
   PubMed Web of Science ®Google Scholar
• Gomez-Lazaro, M., et al. (2007). Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol 71:736–743.
   PubMed Web of Science ®Google Scholar
• Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., Holbrook, N. J. (1996). Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271:4138–4142.
   PubMed Web of Science ®Google Scholar
• Han, Y. H., Kim, S. H., Kim, S. Z., Park, W. H. (2008a). Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33:1099–1105.
   PubMed Web of Science ®Google Scholar
• Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 293:F511–F520.
   PubMed Web of Science ®Google Scholar
• Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2008b). Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59:301–314.
   PubMed Web of Science ®Google Scholar
• Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2008c). Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Cancer Lett 270:40–55.
   PubMed Web of Science ®Google Scholar
• Henson, E. S., Gibson, S. B. (2006). Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Sign 18:2089–2097.
   PubMed Web of Science ®Google Scholar
• Higuchi, Y. (2004). Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8:455–464.
   PubMed Web of Science ®Google Scholar
• Hsin, Y. H., Chen, C. F., Huang, S., Shih, T. S., Lai, P. S., Chueh, P. J. (2008). The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130–139.
   PubMed Web of Science ®Google Scholar
• Jahngen-Hodge, J., et al. (1997). Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272:28218–28226.
   PubMed Web of Science ®Google Scholar
• Kusuhara, M., et al. (1998). p38 kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res 83:824–831.
   PubMed Web of Science ®Google Scholar
• Lee, D. H., Goldberg, A. L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8:397–403.
   PubMed Web of Science ®Google Scholar
• Ling, Y. H., Liebes, L., Zou, Y., Perez-Soler, R. (2003). Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small-cell lung cancer cells. J Biol Chem 278:33714–33723.
   PubMed Web of Science ®Google Scholar
• Mao, X., Yu, C. R., Li, W. H., Li, W. X. (2008). Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 18:879–888.
   PubMed Web of Science ®Google Scholar
• Nagai, H., Noguchi, T., Takeda, K., Ichijo, H. (2007). Pathophysiological roles of ASK1-MAP kinase signaling pathways. J Biochem Mol Biol 40:1–6.
   PubMedGoogle Scholar
• Orlowski, M., Wilk, S. (2000). Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 383:1–16.
   PubMed Web of Science ®Google Scholar
• Orlowski, R. Z. (1999). The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6:303–313.
   PubMed Web of Science ®Google Scholar
• Park, W. H., et al. (2000). Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60:3065–3071.
   PubMed Web of Science ®Google Scholar
• Perez-Galan, P., Roue, G., Villamor, N., Montserrat, E., Campo, E., Colomer, D. (2006). The proteasome inhibitor, bortezomib, induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107:257–264.
   PubMed Web of Science ®Google Scholar
• Poot, M., Teubert, H., Rabinovitch, P. S., Kavanagh, T. J. (1995). De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol 163:555–560.
   PubMed Web of Science ®Google Scholar
• Porter, A. G., Janicke, R. U. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99–104.
   PubMed Web of Science ®Google Scholar
• Qiu, J. H., Asai, A., Chi, S., Saito, N., Hamada, H., Kirino, T. (2000). Proteasome inhibitors induce cytochrome c-caspase-3–like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20:259–265.
   PubMed Web of Science ®Google Scholar
• Rygiel, T. P., Mertens, A. E., Strumane, K., van der Kammen, R., Collard, J. G. (2008). The Rac activator, Tiam1, prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121:1183–1192.
   PubMed Web of Science ®Google Scholar
• Schnelldorfer, T., Gansauge, S., Gansauge, F., Schlosser, S., Beger, H. G., Nussler, A. K. (2000). Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89:1440–1447.
   PubMed Web of Science ®Google Scholar
• Shah, S. A., Potter, M. W., Callery, M. P. (2001). Ubiquitin proteasome pathway: implications and advances in cancer therapy. Surg Oncol 10:43–52.
   PubMed Web of Science ®Google Scholar
• Sigmund, C. D., et al. (1990). Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem 265:19916–19922.
   PubMed Web of Science ®Google Scholar
• Voges, D., Zwickl, P., Baumeister, W. (1999). The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068.
   PubMed Web of Science ®Google Scholar
• Wallach-Dayan, S. B., Izbicki, G., Cohen, P. Y., Gerstl-Golan, R., Fine, A., Breuer, R. (2006). Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290:L790–L796.
   PubMed Web of Science ®Google Scholar
• Yang, J., et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129–1132.
   PubMed Web of Science ®Google Scholar